Abbott New Ovarian Cancer Test Wins FDA Clearance
Abbott has partnered with Fujirebio Diagnostics in the development of the assay. The Architect HE4 assay is also approved for use in Europe, as well as in other
Amberstone Biosciences has signed a partnership and licence agreement with Shanghai Henlius Biotech for conditionally activated T-cell engager candidates to treat solid tumours.
Reportedly, the newly added applications include cardiac multi-chamber analysis with adult and pediatric options that automate atrial and ventricular chamber analysis and leverage low dose CT scanning protocols.
Reportedly, Connect-Rx Release 7.1 provides enhancements to the McKesson’s AcuDose-Rx medication dispensing cabinets and Anesthesia-Rx medication carts. Connect-Rx Release 7.1 has been designed to increase charge capture, expand